| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $41.54M | $47.61M | $45.42M | $42.45M | $28.30M |
| R&D | $23.72M | $34.43M | $33.77M | $35.02M | $20.02M |
| SG&A | $12.41M | $13.18M | $11.65M | $7.44M | $8.28M |
| Operating Income | -$36.63M | -$42.44M | -$40.89M | -$36.95M | -$23.82M |
| Interest Expense | – | – | $2.63M | $0.00 | $64.00K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$173.80M | -$18.92M | -$69.05M | -$36.92M | -$23.16M |
| EPS (basic) | -4.8000 | -0.5200 | -1.9100 | -1.0800 | -0.9600 |
| EPS (diluted) | -4.8000 | -0.8900 | -1.9100 | -1.0800 | -0.9600 |
| Shares (diluted) | $36.24M | $59.06M | $36.08M | $34.29M | $24.10M |